Device for Breathing Frequency Monitoring in Muscular Dystrophy

Status Completed

Clinical Trial Summary

Patients at risk of developing respiratory dysfunctions, such as patients with severe forms of muscular dystrophy, need a careful respiratory assessment, and periodic follow-up visits to monitor the progression of the disease. Continuous monitoring of respiratory activity pattern at home could give additional understandings about disease progression, flanking traditional, intermittent, cardiopulmonary evaluations, allowing prompt clinical intervention, and anticipating respiratory dysfunction. The main objective of the present study is thus to investigate the feasibility of using an innovative wearable device for respiratory monitoring, especially breathing frequency variation assessment, in patients with muscular dystrophy. The comparison between the measurements of breathing frequency obtained by using the IMU-based device and by using the reference method provided optimal results, in terms of accuracy errors, correlation and agreement. Participants positively evaluated the device for what concerns ease of use, comfort, usability and wearability. Moreover, preliminary results confirmed that breathing frequency is an interesting breathing parameter to monitor, at the clinic and at home, because it strongly correlates with the main indexes of respiratory function

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Muscular Dystrophies

Clinical Trial Details

NCT number	NCT04313595
Study type	Interventional
Source	IRCCS Eugenio Medea
Contact
Status	Completed
Phase	N/A
Start date	July 29, 2018
Completion date	July 15, 2019

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01480245` - Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy	Phase 3
Completed	`NCT01153932` - Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy	Phase 2
Completed	`NCT00027391` - Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)	N/A
Recruiting	`NCT04392518` - Telerehabilitation in Proximal Muscle Weakness	N/A
Completed	`NCT03851107` - The Effectiveness of Participation-focused Interventions on Body Functions of Youth With Physical Disabilities	N/A
Completed	`NCT01462292` - A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)	Phase 2
Recruiting	`NCT06094205` - Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)	N/A
Recruiting	`NCT05724173` - Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia	N/A
Recruiting	`NCT03698149` - ECoG BMI for Motor and Speech Control	N/A
Active, not recruiting	`NCT03811301` - [BrainConnexion] - Neurodevice Phase I Trial	N/A
Completed	`NCT05881122` - Anti-inflammatory Diet Consultation for Those With Neuromuscular Disability	N/A
Completed	`NCT04154098` - Evaluation of a Textile Scapula Orthosis	N/A
Recruiting	`NCT05409079` - Schulze Muscular Dystrophy Ability Clinical Study	N/A
Enrolling by invitation	`NCT04009408` - Expiratory Muscle Strength Training (EMST) in Neuromuscular Disorders	N/A
Active, not recruiting	`NCT00674843` - The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies	Phase 1
Recruiting	`NCT02109692` - Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies	N/A
Active, not recruiting	`NCT04045158` - Diaphragm Ultrasound in Neuromuscular Disorders
Not yet recruiting	`NCT03508583` - Turkish Version of The Measure of Processes of Care (MPOC)
Terminated	`NCT01803412` - A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects	Phase 3
Completed	`NCT03406780` - A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy	Phase 2